MedVanta, the leading physician-owned musculoskeletal (MSK) platform, has recently announced a strategic partnership with Remission Medical, the largest national virtual clinic specializing in rheumatology. This collaboration aims to expand rheumatology diagnosis and care for patients across the country.
According to the Centers for Disease Control and Prevention (CDC), one in four U.S. adults suffers from a rheumatic condition, such as arthritis, which can be complex to diagnose and manage. With over 150 different rheumatic diseases, timely diagnosis and treatment are crucial for patients.
Through this partnership, MedVanta and Remission Medical will provide a vertically integrated stack of services, offering comprehensive care for conditions ranging from back pain to inflammatory arthritis. By leveraging advanced technologies and a peer-to-peer provider network, the goal is to streamline the diagnostic and treatment process, reducing the time to treatment initiation significantly.
Prior authorizations are painful for rheumatologists, slow down care, and are circumscribed by the PBMs, said Blake Wehman, Founder & CEO of Remission Medical. Our innovative approach, supported by MedVanta and drug manufacturers, aims to revolutionize the traditional supply chain, ensuring faster access to treatment for patients.
By combining MedVanta’s high-performance network and proven business model with Remission Medical’s technology-enabled services, patients can expect enhanced access to care, improved treatment outcomes, and optimized healthcare costs. This partnership represents a significant step towards advancing value-based care and transforming the MSK healthcare landscape in the United States.
